PMEPA1 and triple-negative breast carcinoma: Our results identified that levels of Smad2 are downregulated in many triple negative breast cancer cells so that Smad3 can positively influence TMEPAI expression, which converts growth inhibitory Smad signaling into growth promoting non-Smad signaling that also promotes cell invasiveness and metastasis.